We create opportunities for lives with the most valuable technologies.

Technology

magAssist Milestone

April 2024
Series D financing Completed. Financing led by Cinda, followed by Suzhou Capital Group and SND Group
April 2024
MoyoAssist® received China NMPA approval
Feb 2024
BreathMo® completed clinical trial
Aug 2023
NyokAssist® received FDA's Breakthrough Device designation
June. 2023
Company name changed as magAssist Co., Ltd.
Mar. 2023
Completed clinical trials of MoyoAssist®
Feb. 2023
Awarded with 2022 Most Popular Employer Brand by DHR Expo Award
Jan. 2023
Awarded with Top 10 MedTech Companies in the Asia-Pacific Region in 2022 by Medtech Outlook APAC
Dec. 2022
Granted as 2022 Potential Unicorn by Jiangsu Government
Nov. 2022
Awarded with FedEx Small Business Grant Contest Special Mention 2022
Sep. 2022
Awarded with Australia Good Design for MoyoAssist® Extra-VAD
Aug. 2022
Awarded Leading Talent of Innovation and Entrepreneurship Project, Gusu
Jun. 2022
Awarded for 2022 Future of Healthcare 100
Awarded for Forbes Asia 100 to Watch
Jan 2022
Awarded Unicorn-Nurtured Company, Suzhou.
Dec 2021
Awarded for 2021 VENTURE 50 by PEdaily.
Dec 2021
Awarded as "Venture 100 Future Unicorn" by CYZONE.
Dec 2021
Awarded as one of the Top 50 Innovative Companies in 21st Century by MIC50.
Nov 2021
Awarded Potential Unicorn by China government.
Oct 2021
Awarded for 2021 REAL 100 Innovators by Jiemian News.
Oct 2021
Series C financing completed. Financing led by Sequoia, followed by CDH and Cenova Ventures.
Aug 2021
First patient treated in clinical trial of MoyoAssist® Extra-VAD
Jan 2021
Series B financing completed. Financing led by Northern Light Venture Capital, followed by SND Ventures Capital Co.
Nov 2020
Awarded Leading Talent of Technology Innovation and Entrepreneurship Project, SND.
Jun 2020
Awarded for Industrial Technology Research Development Joint Fund Project, Medical Device Industry Tech. Innovation Center, Jiangsu.
Feb 2020
Awarded for 2020 Coronavirus Emergency Prevention and Control Technology Project.
Jul 2019
Series A financing completed.
Dec 2018
Awarded for Policy Guided Program (International Technology Collaboration Function), Jiangsu.
May 2018
Awarded Leading Talent of Innovation and Entrepreneurship Project, Gusu.
Jan 2018
Angel round financing completed.
May 2017
magAssist Inc. Founded

Our Team

The Co-founding team

The co-founding team was from the Department of Cardiovascular Engineering (CVE, RWTH Aachen), RWTH Aachen University, Germany. The founding team members were all globally-well-known experts who have years of extensive experience in the development of artificial hearts.



Management team and Employees

Our management team are professionals from the most influential and representative enterprises or national institutions from both domestic and overseas, who have both high-end medical device R&D ability, management skills and strong sales resources.


Most employees graduated from prestigious universities and most of them are researchers.

magAssist Culture

Firm & Trust-worthy
Sincere
Dare-to-dream
Collaborative
Resiliance
Challenge
Our Team